PHOENIX--(BUSINESS WIRE)--Zila, Inc. (NASDAQ:ZILA) today announced that UnitedHealthcare Specialty Benefits (UHSB) began extending coverage for ViziLite® Plus with TBlue™, Zila’s innovative screening device for the early detection of oral abnormalities that could lead to cancer.
